XTX Topco Ltd Reduces Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

XTX Topco Ltd decreased its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 9.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,661 shares of the company’s stock after selling 10,845 shares during the quarter. XTX Topco Ltd owned about 0.10% of Definitive Healthcare worth $311,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Wells Fargo & Company MN lifted its position in Definitive Healthcare by 27.4% during the fourth quarter. Wells Fargo & Company MN now owns 31,297 shares of the company’s stock valued at $129,000 after buying an additional 6,736 shares during the period. Price T Rowe Associates Inc. MD lifted its position in Definitive Healthcare by 20.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company’s stock valued at $85,000 after buying an additional 3,496 shares during the period. Northern Trust Corp lifted its position in Definitive Healthcare by 3.2% during the fourth quarter. Northern Trust Corp now owns 497,279 shares of the company’s stock valued at $2,044,000 after buying an additional 15,530 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Definitive Healthcare by 6.2% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company’s stock valued at $334,000 after buying an additional 4,748 shares during the period. Finally, Geode Capital Management LLC lifted its position in Definitive Healthcare by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company’s stock valued at $5,231,000 after buying an additional 39,938 shares during the period. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on DH. Stifel Nicolaus lifted their price objective on Definitive Healthcare from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday. The Goldman Sachs Group lifted their price objective on Definitive Healthcare from $3.00 to $3.40 and gave the stock a “neutral” rating in a report on Monday, May 12th. BTIG Research downgraded Definitive Healthcare from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $4.88.

Definitive Healthcare Stock Performance

NASDAQ:DH opened at $3.86 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. Definitive Healthcare Corp. has a 1 year low of $2.15 and a 1 year high of $5.68. The stock’s 50 day simple moving average is $3.89 and its two-hundred day simple moving average is $3.61. The company has a market cap of $573.75 million, a price-to-earnings ratio of -1.46, a PEG ratio of 6.50 and a beta of 1.64.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. Definitive Healthcare had a positive return on equity of 3.65% and a negative net margin of 124.43%. The business had revenue of $59.19 million for the quarter, compared to the consensus estimate of $56.20 million. During the same quarter in the previous year, the company posted $0.08 EPS. The company’s revenue was down 6.8% compared to the same quarter last year. As a group, equities analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.